NPR2 and pancreatic adenocarcinoma: Thus, we assessed the relationship between NPR2 expression levels and BLCA, kidney chromophobe (KICH), KIRP, acute myeloid leukemia (LAML), LGG, liver hepatocellular carcinoma (LIHC), MESO, pancreatic adenocarcinoma (PAAD), and STAD.